The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a novel RNA-based fibroblast growth factor receptor response signature (FGFR-PRS) for use in patients with urothelial cancer (UC).
 
Kirk L. Pappan
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
 
Gregory Mayhew
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Patents, Royalties, Other Intellectual Property - GeneCentric
 
James M. Davison
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Patents, Royalties, Other Intellectual Property - GeneCentric
 
Yoichiro Shibata
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Patents, Royalties, Other Intellectual Property - GeneCentric
 
Joel Robert Eisner
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric; Innocrin Pharma
Consulting or Advisory Role - Propella Therapeutics
Patents, Royalties, Other Intellectual Property - Provisional patents for GeneCentric and Innocrin Pharma as part of my employments
 
Kirk Beebe
Employment - GeneCentric
Leadership - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Patents, Royalties, Other Intellectual Property - GeneCentric
 
Michael Vance Milburn
Employment - GeneCentric
Leadership - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Patents, Royalties, Other Intellectual Property - GeneCentric